Listed

BioCardia, Inc.: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 11, 2017 and accepted by EDGAR at May 11, 2017, 16:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-01-01 to 2017-03-31$137.0kus-gaap:Revenues
Research and development3 months2017-01-01 to 2017-03-31$1.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-01-01 to 2017-03-31$1.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-01-01 to 2017-03-31−$2.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-01-01 to 2017-03-31$0us-gaap:InterestExpense
Income tax3 months2017-01-01 to 2017-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-01-01 to 2017-03-31−$2.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-01-01 to 2017-03-31−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure3 months2017-01-01 to 2017-03-31$64.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-03-31$19.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$19.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$19.8mus-gaap:Assets
Current liabilitiesAt period end2017-03-31$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$1.4mus-gaap:Liabilities
Shareholders' equityAt period end2017-03-31$18.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-17-008777. Last ingested by Listed: Nov 13, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.